Epidemiology and Risk Factors for Diabetic Kidney Disease

被引:123
作者
Harjutsalo, Valma
Groop, Per-Henrik
机构
[1] Helsinki Univ Hosp, Dept Med, Div Nephrol, Cent Hosp, FIN-00014 Helsinki, Finland
[2] Univ Helsinki, Folkhalsan Res Ctr, Folkhalsan Inst Genet, Helsinki, Finland
[3] Natl Inst Hlth & Welf, Diabet Prevent Unit, Helsinki, Finland
[4] Univ Helsinki, Diabet & Obes Res Program, Res Programs Unit, Helsinki, Finland
[5] Baker IDI Heart & Diabet Inst, Melbourne, Australia
基金
芬兰科学院;
关键词
Diabetic kidney disease; CKD; ESRD; Risk factors; Epidemiology; STAGE RENAL-DISEASE; UNCHANGED INCIDENCE; DECLINING INCIDENCE; ALBUMIN EXCRETION; PHYSICAL-ACTIVITY; NEPHROPATHY; TYPE-2; COMPLICATIONS; POPULATION; ONSET;
D O I
10.1053/j.ackd.2014.03.009
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Prevalence rates of diabetic kidney disease (DKD) are increasing in parallel with the incidence rates of diabetes mellitus. DKD has already become a significant health problem worldwide. Without radical improvements in prevention and treatment, DKD prevalence will continue to climb. The pathogenesis of DKD is complex and multifactorial, with genetic and environmental factors involved. Several nonmodifiable risk factors contribute to DKD, including genetics, sex, age, age at onset, and duration of diabetes. However, there are also several modifiable risk factors that have a strong effect on the risk of DKD. Traditional modifiable factors include glycemic control, blood pressure, lipids, and smoking. Other recently discovered modifiable risk factors include chronic low-grade inflammation, advanced glycation end products, and lack of physical activity. Efficient management of these modifiable risk factors may improve the prognosis of diabetic patients at risk of DKD. (C) 2014 by the National Kidney-Foundation, Inc. Albrights reserved:
引用
收藏
页码:260 / 266
页数:7
相关论文
共 64 条
[1]  
ANDERSEN AR, 1983, DIABETOLOGIA, V25, P496
[2]  
[Anonymous], IDE DIABETES ATLAS
[3]  
[Anonymous], PAPER PRESENTED AT W
[4]  
[Anonymous], PAPER PRESENTED AT 4
[5]   Prevalence, screening and treatment of chronic kidney disease in people with type 2 diabetes in France: The ENTRED surveys (2001 and 2007) [J].
Assogba, G. F. A. ;
Couchoud, C. ;
Roudier, C. ;
Pornet, C. ;
Fosse, S. ;
Romon, I. ;
Druet, C. ;
Stengel, B. ;
Fagot-Campagna, A. .
DIABETES & METABOLISM, 2012, 38 (06) :558-566
[6]   DECLINING INCIDENCE OF NEPHROPATHY IN INSULIN-DEPENDENT DIABETES-MELLITUS [J].
BOJESTIG, M ;
ARNQVIST, HJ ;
HERMANSSON, G ;
KARLBERG, BE ;
LUDVIGSSON, J .
NEW ENGLAND JOURNAL OF MEDICINE, 1994, 330 (01) :15-18
[7]   The pathobiology of diabetic complications - A unifying mechanism [J].
Brownlee, M .
DIABETES, 2005, 54 (06) :1615-1625
[8]   Smoking in diabetic nephropathy: sparks in the fuel tank? [J].
Chakkarwar, Vishal Arvind .
WORLD JOURNAL OF DIABETES, 2012, 3 (12) :186-195
[9]   Acute-phase markers of inflammation and glomerular structure in patients with type 2 diabetes [J].
Dalla Vestra, M ;
Mussap, M ;
Gallina, P ;
Bruseghin, M ;
Cernigoi, AM ;
Saller, A ;
Plebani, M ;
Fioretto, P .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2005, 16 :S78-S82
[10]   High Burden of Kidney Disease in Youth-Onset Type 2 Diabetes [J].
Dart, Allison B. ;
Sellers, Elizabeth A. ;
Martens, Patricia J. ;
Rigatto, Claudio ;
Brownell, Marni D. ;
Dean, Heather J. .
DIABETES CARE, 2012, 35 (06) :1265-1271